Adrenal gland – Adrenocortical adenoma displaying a weak membranous EPCAM positivity.

Adrenal gland – EPCAM negative adrenocortical adenoma.

Adrenal gland – EPCAM negative pheochromocytoma.

Breast – Invasive breast cancer of no special type (NST) with strong EPCAM immunostaining of tumor cells.

Breast – Invasive lobular breast cancer with moderate EPCAM immunostaining of tumor cells.

Colon – Colorectal adenocarcinoma with strong EPCAM immunostaining of tumor cells.

Esophagus – Adenocarcinoma with strong EPCAM immunostaining of tumor cells.

Esophagus – Squamous cell carcinoma with focal, weak to moderate EPCAM immunostaining of tumor cells.

Kidney – Chromophobe renal cell carcinoma with strong membranous EPCAM immunostaining of tumor cells.

Kidney – Clear cell renal cell carcinoma with weak to moderate membranous EPCAM immunostaining of tumor cells.

Kidney – Papillary renal cell carcinoma with strong basolateral membranous EPCAM immunostaining of tumor cells.

Liver – Cholangiocellular carcinoma with strong EPCAM immunostaining of tumor cells.

Liver – EPCAM negative hepatocellular carcinoma.

Liver – Hepatocellular carcinoma with moderate membranous EPCAM immunostaining.

Lung – Adenocarcinoma with strong EPCAM immunostaining of tumor cells.

Lung – Small cell carcinoma with strong EPCAM immunostaining of tumor cells.

Lymph node – Diffuse large B-cell lymphoma with moderate to strong EPCAM immunostaining of tumor cells.

Ovary – Malignant mixed Mullerian tumor with strong EPCAM immunostaining of epitheloid tumor cells while spindle-shaped tumor cells are negative.

Ovary – Serous high-grade carcinoma with strong EPCAM immunostaining of tumor cells.

Pancreas – Neuroendocrine tumor with strong diffuse EPCAM positivity of tumor cells.

Penis – EPCAM negative squamous cell carcinoma.

Penis – Squamous cell carcinoma with prominent focal membranous EPCAM immunostaining of tumor cells.

Prostate – Adenocarcinoma (Gleason 3+3=6) with strong EPCAM immunostaining of tumor cells.

Skin – Basal cell carcinoma showing strong EpCAM staining of tumor cells.

Skin – Basal cell carcinoma with intense EpCAM positivity of all tumor cells.

Skin – Squamous cell carcinoma lacking EpCAM staining.

Skin – Basal cell carcinoma with intense EpCAM positivity of all tumor cells.

Skin – Basal cell carcinoma showing strong EpCAM staining of tumor cells.

Soft tissue – EPCAM negative leiomyosarcoma.

Stomach – EPCAM negative gastrointestinal stromal tumor (GIST).

Stomach – Gastric adenocarcinoma (diffuse type) with strong membranous EPCAM immunostaining of tumor cells.

Stomach – Gastric adenocarcinoma with strong EPCAM positivity of tumor cells.

Testis – Seminoma with moderate EPCAM immunostaining of tumor cells.

Thorax – EPCAM negative epitheloid malignant mesothelioma.

Thorax – Epitheloid mesothelioma with moderate to strong EPCAM immunostaining of tumor cells.

Thyroid – EPCAM negative anaplastic carcinoma.

Urinary bladder – EPCAM negative small cell carcinoma.

Urinary bladder – Muscle-invasive urothelial carcinoma with strong membranous EPCAM positivity.

Uterus, cervix – Squamous cell carcinoma with weak focal EPCAM positivity.

Uterus, endometrium – Serous carcinoma with strong EPCAM immunostaining of tumor cells.